Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.39 USD | -1.07% | -5.03% | +9.04% |
04:16pm | Trending : Fulcrum Therapeutics, Sanofi in Losmapimod Licensing Deal | DJ |
03:03pm | Fulcrum Therapeutics, Sanofi Sign Licensing Deal for Facioscapulohumeral Muscular Dystrophy Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.04% | 464M | |
+26.52% | 44.96B | |
-0.69% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.48% | 26.08B | |
-21.09% | 19.03B | |
+6.13% | 12.75B | |
+28.39% | 12.06B | |
-3.21% | 11.75B |
- Stock Market
- Equities
- FULC Stock
- News Fulcrum Therapeutics, Inc.
- Transcript : Fulcrum Therapeutics, Inc., Q4 2023 Earnings Call, Feb 27, 2024